ATP7B and Alzheimer disease: Thus, if homozygous ATP7B causes large copper overload, but no specific effect on cognition, why should the Squitti group find a higher prevalence of ATP7B heterozygous variants in the AD population [6,7,8,9], suggesting that such carriers have a higher risk for AD in spite of only mild increase in copper burden?